DJIA 17,959.44 154.64 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

117.46 0.26 (0.22%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SLXP $117.46 0.22%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $116.29
Previous Close $117.20
Daily Range $113.00 - $117.94
52-Week Range $84.62 - $172.98
Market Cap $7.5B
P/E Ratio -93.02
Dividend (Yield) $0.00 (0.0%)
Volume 1,473,618
Average Daily Volume 3,228,235
Current FY EPS -$1.97

Sector

Healthcare

Industry

Drugs

Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website: http://www.salix.com/

News & Commentary Rss Feed

Why Salix Pharmaceuticals, Ltd. Stock Was Clobbered in November

Salix Pharmaceuticals gets clobbered in November after the integrity of its management team is called into question following its third-quarter earnings results.

Benzinga's M&A Chatter for Thursday December 18, 2014

Credit Suisse Raises Salix Pharmaceuticals Price Target

Salix Gains on Destocking Initiatives, Gives 2-Year Outlook - Analyst Blog

#PreMarket Movers From December 16, 2014

Can Salix Pharmaceuticals (SLXP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tap

Can Salix Pharmaceuticals (SLXP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

Ironwood Pharmaceuticals Advances IW-9179 to Phase IIa - Analyst Blog

Pharmaceutical Giant Merck Buys Cubist Pharma

Sterne Agee Says Salix Pharmaceuticals Accounting Concerns Are 'Overdone'

Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews

See More SLXP News...

SLXP's Top Competitors

SLXP $117.46 (0.22%)
Current stock: SLXP
JNJ $106.74 (1.13%)
Current stock: JNJ
NVS $95.30 (0.73%)
Current stock: NVS
RHHBY $34.72 (0.73%)
Current stock: RHHBY